Quick adme quote
Integrated Drug Discovery Services
Accelerate your path to clinic with expert integrated R&D capabilities throughout drug discovery and development
Our comprehensive Integrated Drug Discovery Services provide expert R&D capabilities throughout the entire drug discovery and development journey. With world-leading therapeutic and modality expertise, state-of-the-art capabilities and seamless project management, we support you with a custom-fit integrated drug discovery program to accelerate and derisk your path to clinic.
Expert guidance beyond the Design-Make-Test-Analyze cycle
The complexities presented by an integrated drug discovery program require scientific leadership based on experience at every stage of the Design-Make-Test-Analyze (DMTA) cycle. Encompassing services from initial target identification to clinical development, our expertise spans medicinal chemistry, biology, ADMET/DMPK, and GMP manufacture
However, for our scientists, integrated drug discovery goes beyond working through the DMTA cycle; we offer intellectual input at each phase with the goal of finding the fastest and most robust path to the clinic.
Accelerated studies with integrated services under one roof
A consistent focus on time and cost savings add up to a significant impact over the course of a long term integrated drug discovery program. Consequently, this has shaped the way in which our project teams are created with the added advantage of all core services being situated under one roof at our central UK facility.
Scientific leads from drug discovery disciplines across the project work in a concerted manner to problem solve and deliver milestones. This truly enables the team to quickly mitigate risk and keep the project advancing.
Alongside this, a dedicated project manager ensures key deadlines and deliverables are met through a focus on operational aspects of your project.
Data management and innovative platforms
Dotmatics ELN provides essential peace of mind for the storage and management of your project data and intellectual property. Data is seamlessly transferred across the whole project team, enabling highly efficient DMTA cycling and to truly accelerate the decision making process.
Innovation is at the forefront of drug discovery ethos and we pride ourselves on relentlessly developing impactful technologies and solutions that benefit our clients. Two recent examples are:
- BioPALs, an AI powered tool for hit identification that takes a fraction of the time and cost of other methods
- In-CERT employs state of the art techniques to provide detailed insights into the physical properties, payload, efficacy, mechanism of action and immuno safety of your therapeutic product
Learn more about how we can help you advance your therapeutic to the clinic with an integrated drug discovery program tailored to your needs.
Download and resource links:
Get started today